09887.HK
Nanjing Leads Biolabs Co Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 64.00
−5.47%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.75x
- Price / sales
- 55.81x
- Price / cash flow
- -413.82x
Enterprise value
- Enterprise value
- HKD 11.1B
- EV / sales
- 48.60x
- EV / EBITDA
- -217.50x
- EV / EBIT
- -173.22x
- Market cap
- HKD 12.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025